(SMMT) Summit Therapeutics Weekly charts technical analysis
(SMMT) Summit Therapeutics Weekly charts technical analysis Weekly analysis of Summit Therapeutics | Buy/Sell Summit Therapeutics
Summit Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Summit Therapeutics is 3232420
| Date | Closing Price | Open | High | Low | Volume |
| 22 Fri Aug 2025 | 26.20 | 26.27 | 27.00 | 24.77 | 12.907 Mn |
| 15 Fri Aug 2025 | 26.69 | 28.75 | 29.36 | 24.16 | 19.713 Mn |
| 08 Fri Aug 2025 | 28.66 | 29.05 | 30.98 | 27.10 | 9.776 Mn |
| 01 Fri Aug 2025 | 27.07 | 28.71 | 28.71 | 25.41 | 11.321 Mn |
| 25 Fri Jul 2025 | 28.67 | 26.51 | 29.07 | 25.81 | 10.364 Mn |
| 18 Fri Jul 2025 | 26.20 | 25.10 | 28.62 | 24.09 | 16.277 Mn |
| 11 Fri Jul 2025 | 25.00 | 23.60 | 26.33 | 22.16 | 16.852 Mn |
| 03 Thu Jul 2025 | 24.55 | 20.79 | 25.94 | 20.33 | 20.759 Mn |
| 27 Fri Jun 2025 | 20.60 | 20.49 | 21.82 | 19.48 | 23.926 Mn |
| 20 Fri Jun 2025 | 20.56 | 19.71 | 20.64 | 19.51 | 8.495 Mn |
Indicators analysis of Summit Therapeutics (SMMT)
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Summit Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Summit Therapeutics in short term and the buy signal is strong.
Summit Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Summit Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 25.09 and Summit Therapeutics (SMMT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Summit Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Summit Therapeutics in short term and the buy signal is strong.
Summit Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Summit Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 25.09 and Summit Therapeutics (SMMT) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.